GlassScriptPhysician profile
Dalibel Bravo
NPI 1053722744
$9,469.20
in general payments reported to CMS, 2019-2025
24 companies · $993 in 2025
The $993 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,432 · 2022: $2,014 · 2023: $519 · 2024: $511 · 2025: $993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,876 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,876.42 |
| Long Term Medical Supply Or Device Loan | $146.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,710.87 | 2021-2025 | Avance Nerve Graft |
| Arthrex, INC. | $2,226.89 | 2021-2024 | |
| Encore Medical, LP | $1,042.63 | 2021 | |
| Skeletal Dynamics INC | $657.02 | 2021-2023 | Geminus, Ijs, Align |
| Integra Lifesciences Corporation | $517.56 | 2021-2024 | Integra, Acell, Tenoglide |
| Trimed, INC. | $482.50 | 2025 | |
| Embody, INC. | $235.45 | 2022 | |
| Trice Medical, INC. | $234.84 | 2022-2023 | |
| Endo USA, INC. | $168.93 | 2025 | Xiaflex |
| Checkpoint Surgical, INC | $142.16 | 2021-2023 | Checkpoint Stimulators |
| Sanara Medtech INC. | $139.54 | 2024-2025 | Celleraterx, Celleraterx |
| Southern Edge Orthopaedics, INC. | $139.10 | 2024 | |
| Smith+Nephew, INC. | $138.67 | 2021 | |
| Endo Pharmaceuticals INC. | $134.96 | 2021-2024 | Xiaflex |
| Organogenesis INC. | $125.00 | 2024 | Puraply Wound Matrix |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $87.25 | 2022 | |
| Stryker Corporation | $60.46 | 2022 | |
| Bioventus LLC | $41.08 | 2023-2025 | Xcell, Exogen Ultrasound Bone Healing System |
| Djo, LLC | $39.74 | 2025 | Cmf |
| Zimmer Biomet Holdings, INC. | $37.98 | 2023 | Tapestry |
| Amgen INC. | $31.80 | 2024 | Evenity, Prolia |
| Kowa Pharmaceuticals America, INC. | $28.20 | 2022 | |
| Ossio INC | $27.74 | 2021 | |
| Vericel Corporation | $18.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dalibel Bravo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.